21
Participants
Start Date
November 24, 2023
Primary Completion Date
May 16, 2024
Study Completion Date
May 16, 2024
Lab Demo 1.0
"Lowering of the participants blood glucose with the application of insulin to induce hypoglycaemia, followed by the application of glucose to induce hyperglycaemia and finally insulin to restore euglycemia.~During the different glycaemia states, transcutaneous spectral data are collected continuously with the device and paired with reference measurements (venous blood and interstitial fluid)."
Markus Laimer, Bern
Lead Sponsor
Collaborators (1)
DCB Research AG
OTHER
Liom Health AG
INDUSTRY